<output id="hjdj7"><big id="hjdj7"><ruby id="hjdj7"></ruby></big></output>

<del id="hjdj7"></del>

<ins id="hjdj7"></ins>
    <ins id="hjdj7"><big id="hjdj7"><del id="hjdj7"></del></big></ins>

    <b id="hjdj7"></b>
    <ins id="hjdj7"><big id="hjdj7"><output id="hjdj7"></output></big></ins>

    <b id="hjdj7"><form id="hjdj7"><output id="hjdj7"></output></form></b>
    Current Location:Home > ENGLISH > Product Center >

    High-energy bio-ion instrument for Coronary Artery Disease

    New breakthroughs of Physical therapeutic instrument for coronary Artery disease


    Product Name
     High-energy Bio-ion Instrument for Coronary Artery Disease

    Product Structure
    Host  Output line  Two Physical probe

    Mechanism of action
    According to the conductance fundamental equilibrium principle of biological electrophysiological and biological tissue ,High-energy bio-ion instrument for coronary artery disease convert biological ion wave to bio-electric ion  and re-integrate the disordered charge for diseased tissue( nerves, bloods, muscles) to restore their normal function when it effects on human body. Especially its high technology not only broke through the difficulties that traditional physical therapy factor is hard to penetrate deeply into human organs and tissues, but also according to the principle of TCM meridian, combined the therapy of acupuncture and moxibustion with the effect of biological ionizing to get excellent physiological and therapeutic effects, and achieve its effect:
    a. Restore the vasomotion in resistance vessel, relieve wall fibrosis, change the status of vascular stenosis,make the vascular softened and reduce blood pressure.
    b. Improve microcirculation, increase myocardialinfarction lesion area's blood provide, as well as improve the ischemic injury of myocardial tissue and promote nerve function to activate.
    c. Relieve myocardial degeneration and the fibrillation of myocardial cell atrophy interstitial, improve coronary atherosclerosis and the status of cardiac hypertrophy.
    d. Increase the motion of electric charges of nerve cells membrane (inside and outside);improve nerve inflammation edema, enhance the activity of neuronal cell and resurrect nerve function.



     Clinical characteristics
    a. Short-term treatment will significantly improve the main symptoms of angina and shortness of breath.
    b. Long-term treatment will improve the blood supply of coronary, repair the organization of myocardial infarction, delay the progress of disease, and make patients to full recovery. No any treated patient is happened depends on heart surgery or cardiac interventional treatment due to the protracted illness.
    c. It has been proved by case-by –case that the methods for rescuing patients with acute myocardial infarction are more effective than regular methods.
    d. Simply physical treatment, safety, no toxic side effect.

    Adaptation disease
    a.Initial onset angina pectoris: patients with angina pectoris within one month.
    b.Stable angina pectoris: patients with angina pectoris more than one month
    c.Progressive angina pectoris: chest pain that induced by the same degree of fatigue is happen frequency, the severity and duration is also suddently increasing.
    d.It has been tested and confirmed as the treatment of patients with acute myocardial infarction in acute and convalescent stages.

    Exclusion criteria
    a. Angina pectoris at test
    b. The chest pain caused by other heart disease, severe neurosis, menopausal syndrome, cervical spondylosis, gallbladder and the reflux of stomach and esophageal.

    a. Patients who had cardiac surgery or interventional cardiology treatment.
    b. Patients with severe primary disease, including severe hypertension, severe cardiopulmonary dysfunction, severe arrhythmia, as well as the severe primary disease caused by liver, kidney, and hematopoietic system.
    c. Patients with malignant tumors, bone deformities, internal bleeding, glaucoma and other serious diseases.
    d. Psychiatric patients
    e. Pregnant or lactating women
    f. Children under 12 years old.


    Methods of operation
    Patients with posterior wall myocardial infarction are proposal method A; patients with anterior wall myocardial infarction are proposal method B.

    Method A: Place two physical probes in parallel to patients’ back [figure 1]
    Let the patient supine to press the physical probes, setting the treatment time for 20 minutes, then slowly adjusting the fine-tuning to make the treatment current increase to the patient tolerance. The best treatment current is 10-20 mA, plus the stalls when current is not enough, and the current should not exceed 30 mA.

    a. The product specification of high-energy bio-ion instrument for coronary artery disease must be read before operation.
    b. Clean the treatment site' skin with saline before the implementation of the treatment, then directly place the physical probes on the treatment sites
    c. To avoid frozen physical probes stimulate patients’ skin, the physical probes must be soaked in warm water  when make the  treatment in a low temperature environment .
    d. It must be explained to the patients that it is a normal phenomenon if they complain the skin is a little uncomfortable during the treatment. Reduce the stalls to relieve the irritation if the patients feel unbearable. Smear medical Vaseline at the treatment sites to reduce patients’ discomfort after the treatment if patients' skin  contacted with physical probes appear to allergies. And appropriately prompt patients in order to eliminate their concerns.
    e. Immediately stop treating and to take appropriate relief measure if patients occur other concurrent symptoms in the course of treatment.

    Treatment arrangements


    1.The treatment for Initial onset angina pectoris
    Twice a day, each time 20 minutes. Course of treatment should be increased until the major indexes have improved to achieve effective standards if the efficacies of main symptoms have improved after three times’ treatments. Then take the re-examination and follow-up the efficacy after 30 days.Give up this treatment method if it failed to improve the main symptom efficacy or major indexes after the treatment accumulated to five times.
    2.The treatment for stable angina pectoris:
    Twice a day, each time 20 minutes. Course of treatment should be increased until the major indexes have improved to achieve effective standards if the efficacies of main symptoms have improved after five times’treatments. Then take the re-examination and follow-up the efficacy after 20 days. Give up this treatment method if it failed to improve the main symptom efficacy or major indexes after the treatment accumulated to ten times.
    3.Treatment for Progressive angina pectoris
    Twice a day, each time 20 minutes. Course of treatment should be increased until the major indexes have improved to achieve effective standards if the efficacies of main symptoms have improved after five times’ treatments. Then take the re-examination and follow-up the efficacy after 20 days. Give up this treatment method if it failed to improve the main symptom efficacy or major indexes after the treatment accumulated to twenty times for ten days.
    4.Treatment for rescuing the patients with acute myocardial infarction.
    Reference  Method1,Method2 or Method3
    5.The convalescent treatment for the patients with acute myocardial infarction
    Reference Method 1, Method 2 or Method 3.
    Adverse reactions

    Clinical reports

     [摘要]:目的 探討高能生物離子治療穩定型和不穩定型心絞痛患者的療效。方法選擇冠心病心絞痛患者,給予常規抗心絞痛治療(抗心肌缺血藥物+抗血小板藥物、抗凝藥),分成兩組進行觀察。
     ?、趯φ战M:僅給予常規治療。觀察指標為心絞痛癥狀緩解率、心電圖改善程度。結果 治療后不穩定型心絞痛癥狀緩解有效率為90%,穩定型心絞痛癥狀緩解有效率為96.15%;心電圖缺血改善有效率為86.27%,治療后的24h動態心電圖ST段總壓低時間縮短以及ST段最大壓低深度減少情況,與治療前比較有明顯改善,P<0.05。
    結論 高能生物離子對心絞痛癥狀的近期改善有著肯定的療效,值得臨床進一步觀察和推廣。
    [關鍵詞]:高能生物離子 心絞痛
    Clinical Analysis of Therapeutic Efectiveness on the patients of Angina Pectoris of Coronary Artery Disease with High-energy Bio-ion YAO Zhen,Chen Jing, Kong Yueqiong, Zheng Hailong, Rong Congwen, Liu Chan
    Abstract Objectives To observe the therapeutic effectiveness of high-energy bio-ion in treatment of patients with angina pectoris of coronary artery disease. Methods 56 caese of coronary heart disease were divided into two groups: unstable angina pectoris (UAP) and stable angina pectoris (SAP). All of them weregiven with antimyocardial ischemia drugs. Some of them were also treated with high-energy bio-ion equipment (therapy group), which was manufactured by Hainan Tianguang Hi-technology Development Corporation and treated in 40 minutes per session, 10 sessions per course. Some of them were given only with antimyocardial ischemia drugs (control group). Rsults After therapy, the effective rate of symptom im provement in UAP group was 90% and in SAP was 96.15%. The effective rate of ECG improvement of ischemia in all patients was improved greatly. Conclusion The high-energy bio-ion is much effective for the recent action in angina pectoris.
    [Key words]:high-energy bio-ion angina pectoris
    1.1 病例選擇:

    結 果

            顯效         有效         無效        合計
    UAP組  16           11           3            30      
    SAP組  17           8            1            26
    合計    33           19           4            56

     2.2. 心電圖恢復情況:

    表二 治療前后靜息心電圖NST與∑ST比較(X±S) 
              治療前                             治療后
    NST       2.8±1.2                          2.2±1.2
    ∑ST      3.2±1.7                          2.3±1.1


    表三 治療前后靜息心電圖NST與∑ST比較(X±S) 
              治療前                             治療后
    ST段總壓低時間(min)    504±40.2                546±51.2
    ST段最大壓低深度(mm)    3.6±1.5                2.5±1.2


    表四 治療前后血液流變學情況
                               UAP組                 SAP組
                          前        后            前         后
    TC(mmol/L)     5.85±0.82   5.12±0.94   5.67±0.73   5.03±0.81
    Tg(mmol/L)     2.07±0.46   1.87±0.47   2.13±0.32   1.98±0.53
    SOD(ng/L)      786±71.8    812±85.6    759±82.8    794±91.2
    F(ng/L)         4.6±2.1    3.1±1.6    4.3±1.8     3.0±1.2
    FDP(mg/L)      1.6±0.7     1.2±0.2      1.7±0.5     1.3±0.3

    血液低切變速率  8.73±0.97   7.65±0.89   7.97±0.88   7.21±0.63
    血液高切變速率 6.57±0.74   6.11±0.38    5.63±0.59   4.89±0.42
    血漿粘度      1.43±0.31    1.06±0.23    1.52±0.27   1.02±0.24
    PAG(M)%       76.19±12.78  70.12±8.43 77.67±9.24   70.89±8.97

    討 論